Chronic hypoxia triggers pulmonary vasculopathy and NF-κB expression, and NF-κB inhibition reverses hypoxia-induced pulmonary vascular remodeling and right ventricular hypertrophy (20). The gene discussed is NFKB1; the disease is Right ventricular hypertrophy.